Galmed Pharmaceuticals Ltd. (GLMD) Form 6-K — Jun 22, 2026
Galmed Pharmaceuticals Ltd. announced the consummation of its acquisition of Colospan Ltd. on June 22, 2026. The transaction was completed pursuant to an amended share purchase agreement that modified the structure of the purchase consideration.
Key figures
- Debt Amount
- 0
- Cash Position
- 0
- Deal Value Usd
- 3300000
- Earnout Cap
- 2000000
- Earnout Start
- 2027-07-01
- Earnout Tier1 Rate
- 7%
- Earnout Tier2 Rate
- 9%
- Earnout Tier1 Threshold
- 5000000
- Earnout Tier2 Threshold
- 12000000
- Acceleration Financing Threshold
- 17500000
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.